2019

1. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication

   Therapeutic Advances in Medical Oncology, Vol. 11

2. Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study

   Breast Cancer Research and Treatment, Vol. 177, Núm. 1, pp. 115-125

3. Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)

   Scientific Reports, Vol. 9, Núm. 1